netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Methylphenidate found 9 matches
Open monograph to display formulary status BNF Category
  Controlled Drug Methylphenidate Central nervous system - CNS stimulants and other drugs used for attention deficit hyperactivity disorder - 04.04
  Methylphenidate
(Giggle incontinence) 		Obstetrics, Gynaecology, and urinary-tract disorders - Urinary incontinence - 07.04.02
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section Methylphenidate, Dexamfetamine, Lisdexamfetamine and Atomoxetine for treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults (04.04)
link in drug section MHRA Drug Safety Update (Sep 2022): Methylphenidate long-acting (modified-release) preparations: caution if switching between products due to differences in formulations (07.04.02)
link in drug section North of Tyne, Gateshead and North Cumbria - Methylphenidate for Narcolepsy Shared Care Guidance (March 2023) (04.04)
link in drug section North of Tyne, Gateshead and North Cumbria Shared Care Guideline - Methylphenidate secondary to brain injury (04.04)
link in drug section South Tyneside & Sunderland APC Shared Care Guidance - Methylphenidate, Dexamfetamine, Lisdexamfetamine and Atomoxetine for treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Adults (04.04)
link in drug section South Tyneside & Sunderland APC Shared Care Guidance - Methylphenidate, Dexamfetamine, Lisdexamfetamine, Atomoxetine and Guanfacine for treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children and Young People (04.04)
link in drug section TEWV Methylphenidate Shared Care Guideline (04.04)


 
netFormulary